Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.760
+0.050 (2.92%)
Feb 21, 2025, 4:00 PM EST - Market closed
Immuneering Market Cap
Immuneering has a market cap or net worth of $54.65 million as of February 21, 2025. Its market cap has decreased by -67.24% in one year.
Market Cap
54.65M
Enterprise Value
8.23M
1-Year Change
-67.24%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $54.65M, a decrease of -85.06%. That is a compound annual growth rate of -41.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 54.65M | -20.00% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |